Hypothermia reduces secretion of vascular endothelial growth factor by cultured retinal pigment epithelial cells

British Journal of Ophthalmology

Volumn 94, Issue 12, 2010, Pages 1678-1683

  Coassin, Marco ^a   Duncan, Keith G ^a   Bailey, Kathy R ^a   Singh, Ajay ^a   Schwartz, Daniel M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; THIOPENTAL; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL METABOLISM; HYPOTHERMIA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN SECRETION; TEMPERATURE SENSITIVITY;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPOTHERMIA, INDUCED; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 78649824873     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.168864     Document Type: Article

References (71)

1. de Jong PT. Age-related macular degeneration. N Engl J Med 2006;355:1474-85.
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
3. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 1995;92:10457-61.
4. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000;55:15-35;discussion 35-6.
5. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9. (Pubitemid 20066716)
6. Mousa SA, Lorelli W, Campochiaro PA. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem 1999;74:135-43. (Pubitemid 29270036)
7. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
8. Pournaras CJ, Miller JW, Gragoudas ES, et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol 1997;115:1553-8.
9. Whikehart DR. Biochemistry of the eye. 2nd edn, Philadelphia, PA: Butterworth-Heinemann, 2003.
10. Das A, McGuire PG. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 2003;22:721-48. (Pubitemid 37298046)
11. Sakamoto T, Sakamoto H, Murphy TL, et al. Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. Arch Ophthalmol 1995;113:512-20.
12. Young TA, Wang H, Munk S, et al. Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 2005;80:651-62.
13. Ghiso N, Rohan RM, Amano S, et al. Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP. Invest Ophthalmol Vis Sci 1999;40:1033-9. (Pubitemid 29211440)
14. Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23:91-147.
15. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2004;242:91-101. (Pubitemid 38208289)
16. Zhang SX, Ma JX. Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 2007;26:1-37.
17. Singer D, Bretschneider HJ. Metabolic reduction in hypothermia: pathophysiological problems and natural examples - Part 2. Thorac Cardiovasc Surg 1990;38:212-19. (Pubitemid 20267020)
18. Singer D, Bretschneider HJ. Metabolic reduction in hypothermia: pathophysiological problems and natural examples - Part 1. Thorac Cardiovasc Surg 1990;38:205-11. (Pubitemid 20267019)
19. Liu L, Yenari MA. Therapeutic hypothermia: neuroprotective mechanisms. Front Biosci 2007;12:816-25.
20. Geiser F. Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu Rev Physiol 2004;66:239-74. (Pubitemid 40614445)
21. Globus MY, Alonso O, Dietrich WD, et al. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem 1995;65:1704-11.
22. Pang Z, Geddes JW. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J Neurosci 1997;17:3064-73.
23. Horiguchi T, Shimizu K, Ogino M, et al. Postischemic hypothermia inhibits the generation of hydroxyl radical following transient forebrain ischemia in rats. J Neurotrauma 2003;20:511-20.
24. Maier CM, Sun GH, Cheng D, et al. Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis 2002;11:28-42.
25. Chi OZ, Liu X, Weiss HR. Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia. Anesthesiology 2001;95:933-8.
26. Dorotta I, Kimball-Jones P, Applegate R 2nd. Deep hypothermia and circulatory arrest in adults. Semin Cardiothorac Vasc Anesth 2007;11:66-76.
27. Wang KK, Larner SF, Robinson G, et al. Neuroprotection targets after traumatic brain injury. Curr Opin Neurol 2006;19:514-19.
28. Jiang JY, Yang XF. Current status of cerebral protection with mild-to-moderate hypothermia after traumatic brain injury. Curr Opin Crit Care 2007;13:153-5.
29. Hemmen TM, Lyden PD. Induced hypothermia for acute stroke. Stroke 2007;38:794-9.
30. Sacco RL, Chong JY, Prabhakaran S, et al. Experimental treatments for acute ischaemic stroke. Lancet 2007;369:331-41.
31. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care. J Neurol Sci 2007;261:118-26.
32. Schulzke SM, Rao S, Patole SK. A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy - are we there yet? BMC Pediatr 2007;7:30.
33. Shah PS, Ohlsson A, Perlman M. Hypothermia to treat neonatal hypoxic ischemic encephalopathy: systematic review. Arch Pediatr Adolesc Med 2007;161:951-8.
34. Rinkoff J, Machemer R, Hida T, et al. Temperature-dependent light damage to the retina. Am J Ophthalmol 1986;102:452-62.
35. Zilis JD, Chandler D, Machemer R. Clinical and histologic effects of extreme intraocular hypothermia. Am J Ophthalmol 1990;109:469-73.
36. Tamai K, Majima A, Yan C. Effects of local hypothermia on uveal blood flow and postoperative inflammation in vitrectomy. Jpn J Ophthalmol 1995;39:43-8.
37. Tamai K, Toumoto E, Majima A. Protective effects of local hypothermia in vitrectomy under fluctuating intraocular pressure. Exp Eye Res 1997;65:733-8.
38. Quinones-Hinojosa A, Malek JY, Ames A 3rd, et al. Metabolic effects of hypothermia and its neuroprotective effects on the recovery of metabolic and electrophysiological function in the ischemic retina in vitro. Neurosurgery 2003;52:1178-86; discussion 1186-7.
39. Kunikata H, Abe T, Murata H, et al. Hypothermia of 8 degrees C protects cultured retinal pigment epithelial cells and retinal ganglion cells against trypan blue toxicity. Am J Ophthalmol 2006;141:754-6.
40. Kunikata H, Tomita H, Abe T, et al. Hypothermia protects cultured human retinal pigment epithelial cells against indocyanine green toxicity. J Ocul Pharmacol Ther 2007;23:35-9.
41. Maynard KI, Quinones-Hinojosa A, Malek JY. Neuroprotection against ischemia by metabolic inhibition revisited. A comparison of hypothermia, a pharmacologic cocktail and magnesium plus mexiletine. Ann N Y Acad Sci 1999;890:240-54.
42. Wang X, Niwa M, Hara A, et al. Neuronal degradation in mouse retina after a transient ischemia and protective effect of hypothermia. Neurol Res 2002;24:730-5.
43. Tamai K, Toumoto E, Majima A. Local hypothermia protects the retina from ischaemic injury in vitrectomy. Br J Ophthalmol 1997;81:789-94.
44. Faberowski N, Stefansson E, Davidson RC. Local hypothermia protects the retina from ischemia. A quantitative study in the rat. Invest Ophthalmol Vis Sci 1989;30:2309-13.
45. Chen CS, Lee AW. Management of acute central retinal artery occlusion. Nat Clin Pract Neurol 2008;4:376-83.
46. Pulido JS, Fukuda M, Howe CA, et al. Barbiturates protect retinal cells from hypoxia in cell culture. Arch Ophthalmol 1989;107:1809-12.
47. Shen CC, Huang HM, Ou HC, et al. Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J Biomed Sci 2004;11:472-81.
48. Liu H, Dai T, Yao S. Effect of thiopental sodium on N-methyl-D-aspartate- gated currents. Can J Anaesth 2006;53:442-8.
49. Falk G, Freeman A, Marshall T, et al. Reversal and inhibition of cholera toxin-induced secretion in isolated rabbit ileum. J Physiol 1990;421:399-409.
50. Zager EL, Ames A 3rd. Reduction of cellular energy requirements. Screening for agents that may protect against CNS ischemia. J Neurosurg 1988;69:568-79.
51. Fujita J. Cold shock response in mammalian cells. J Mol Microbiol Biotechnol 1999;1:243-55.
52. Ning XH, Chi EY, Buroker NE, et al. Moderate hypothermia (30 degrees C) maintains myocardial integrity and modifies response of cell survival proteins after reperfusion. Am J Physiol Heart Circ Physiol 2007;293:H2119-28.
53. Ohta H, Terao Y, Shintani Y, et al. Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci Res 2007;57:424-33.
54. Han HS, Yenari MA. Effect on gene expression of therapeutic hypothermia in cerebral ischemia. Future Neurol 2007;2:435-40.
55. Gundersen Y, Vaagenes P, Pharo A, et al. Moderate hypothermia blunts the inflammatory response and reduces organ injury after acute haemorrhage. Acta Anaesthesiol Scand 2001;45:994-1001.
56. Vosler PS, Logue ES, Repine MJ, et al. Delayed hypothermia preferentially increases expression of brain-derived neurotrophic factor exon III in rat hippocampus after asphyxial cardiac arrest. Brain Res Mol Brain Res 2005;135:21-9.
57. Rissanen E, Tranberg HK, Sollid J, et al. Temperature regulates hypoxia-inducible factor-1 (HIF-1) in a poikilothermic vertebrate, crucian carp (Carassius carassius). J Exp Biol 2006;209:994-1003.
58. Tanaka T, Wakamatsu T, Daijo H, et al. Persisting mild hypothermia suppresses hypoxia-inducible factor 1α protein synthesis and HIF-1-mediated gene expression. Am J Physiol Regul Integr Comp Physiol 2010;298:R661-71.
59. Scott IU, Edwards AR, Beck RW, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-7.
60. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-25.
61. Hsu J, Kaiser RS, Sivalingam A, et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina 2007;27:1013-19.
62. Fischer S, Renz D, Wiesnet M, et al. Hypothermia abolishes hypoxia-induced hyperpermeability in brain microvessel endothelial cells. Brain Res Mol Brain Res 1999;74:135-44.
63. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003;121:547-57.
64. Nguyen QD, Shah SM, Van Anden E, et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004;45:617-24.
65. Lu L, Hackett SF, Mincey A, et al. Effects of different types of oxidative stress in RPE cells. J Cell Physiol 2006;206:119-25.
66. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115-34.
67. Parver LM, Auker CR, Carpenter DO. The stabilizing effect of the choroidal circulation on the temperature environment of the macula. Retina 1982;2:117-20.
68. Geiser MH, Bonvin M, Quibel O. Corneal and retinal temperatures under various ambient conditions: a model and experimental approach. Klin Monbl Augenheilkd 2004;221:311-14.
69. Hasegawa T, McLeod DS, Bhutto IA, et al. The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev Dyn 2007;236:2089-100.
70. Lutty G, Grunwald J, Majji AB, et al. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis 1999;5:35.
71. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598-614.